Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 2 of 2: Calculated dose response metrics - Dataset (ID:20344)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Primary Target | Pathway | GR50 | GRmax | GR_AOC | Death_AUC | GR Hill Coefficient | GEC50 | GR r2 |
---|---|---|---|---|---|---|---|---|---|---|
BT-20 | Trametinib | MEK | MAPK/nRTK | 2.3446 | 0.5034 | 0.1768 | 0.0535 | 0.6346 | 0.053945 | 0.96232 |
CAL-51 | Trametinib | MEK | MAPK/nRTK | Inf | 0.7064 | 0.0662 | 0.0124 | 0.8944 | 0.19105 | 0.98439 |
MDA-MB-134-VI | Trametinib | MEK | MAPK/nRTK | 0.0020578 | -0.2707 | 0.7601 | 0.0782 | 1.0824 | 0.0028809 | 0.99008 |
MDA-MB-468 | Trametinib | MEK | MAPK/nRTK | 0.4421 | 0.4075 | 0.2132 | 0.0255 | 0.4592 | 0.27448 | 0.99227 |
HCC1806 | Trametinib | MEK | MAPK/nRTK | Inf | 0.7036 | 0.1086 | 0.0280 | 4.8006 | 0.007609 | 0.89189 |
HCC1954 | Trametinib | MEK | MAPK/nRTK | 0.016729 | 0.2287 | 0.4005 | 0.0565 | 0.8524 | 0.0082359 | 0.9993 |
CAMA-1 | Trametinib | MEK | MAPK/nRTK | 4.9546 | 0.5526 | 0.1688 | 0.0031 | 0.5322 | 0.09227 | 0.9741 |
PDX1328 | Trametinib | MEK | MAPK/nRTK | 0.018054 | 0.2490 | 0.3349 | 0.0167 | 1.3148 | 0.0076303 | 0.97089 |
HCC1500 | Trametinib | MEK | MAPK/nRTK | 0.14491 | 0.3439 | 0.2190 | 0.0408 | 0.9370 | 0.049167 | 0.9913 |
Hs 578T | Trametinib | MEK | MAPK/nRTK | 0.0063584 | 0.1931 | 0.4907 | 0.0713 | 0.9022 | 0.0036513 | 0.99154 |
SK-BR-3 | Trametinib | MEK | MAPK/nRTK | Inf | 0.6828 | 0.1817 | 0.0154 | 1.1257 | 0.0059643 | 0.93505 |
CAL-85-1 | Trametinib | MEK | MAPK/nRTK | 0.013202 | 0.2343 | 0.4101 | 0.1186 | 0.9630 | 0.007054 | 0.99004 |
PDX1258 | Trametinib | MEK | MAPK/nRTK | Inf | 0.8500 | 0.0424 | 0.0050 | 4.9997 | 0.028253 | 0.88698 |
HCC1937 | Trametinib | MEK | MAPK/nRTK | Inf | 0.6885 | 0.1384 | 0.0485 | 1.0415 | 0.012758 | 0.98277 |
MCF 10A | Trametinib | MEK | MAPK/nRTK | 0.0033619 | 0.2252 | 0.5266 | -0.0015 | 1.2096 | 0.0021432 | 0.99763 |
HCC1143 | Trametinib | MEK | MAPK/nRTK | 0.0088297 | -0.0225 | 0.5379 | 0.1187 | 0.5756 | 0.013291 | 0.99613 |
HCC70 | Trametinib | MEK | MAPK/nRTK | 0.0019047 | -0.0393 | 0.6924 | 0.1954 | 0.8693 | 0.0021049 | 0.98467 |
MDA-MB-231 | Trametinib | MEK | MAPK/nRTK | 0.0026306 | -0.1785 | 0.7224 | 0.2816 | 1.1618 | 0.0033911 | 0.99829 |
HCC38 | Trametinib | MEK | MAPK/nRTK | 0.22023 | 0.1854 | 0.2076 | 0.0234 | 0.6910 | 0.35783 | 0.98881 |
HCC1419 | Trametinib | MEK | MAPK/nRTK | 0.031029 | 0.4259 | 0.2875 | -0.0031 | 1.4893 | 0.0089457 | 0.98063 |
SUM159PT | Trametinib | MEK | MAPK/nRTK | 0.0055877 | 0.2792 | 0.4613 | 0.0039 | 0.9923 | 0.0023029 | 0.99862 |
SUM1315MO2 | Trametinib | MEK | MAPK/nRTK | 0.021115 | 0.1329 | 0.3887 | 0.0532 | 1.0540 | 0.01638 | 0.99458 |
HME1 | Trametinib | MEK | MAPK/nRTK | 0.0057339 | 0.2032 | 0.4387 | 0.0257 | 2.4280 | 0.0044228 | 0.99436 |
HCC1428 | Trametinib | MEK | MAPK/nRTK | Inf | 0.8152 | 0.0767 | 0.0025 | 5.0000 | 0.024413 | 0.9037 |
T47D | Trametinib | MEK | MAPK/nRTK | Inf | 0.5801 | 0.2130 | 0.0041 | 0.9941 | 0.0048584 | 0.90394 |